Detalhe da pesquisa
1.
Incidence, treatment, and outcomes of acute myocardial infarction following transcatheter or surgical aortic valve replacement.
Catheter Cardiovasc Interv;
99(3): 877-888, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34236762
2.
Successful modeling of long term outcomes in end-stage renal disease patients undergoing percutaneous coronary intervention with drug-eluting stents.
Catheter Cardiovasc Interv;
98(2): 208-214, 2021 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33913614
3.
End-stage renal disease as an independent risk factor for in-hospital mortality after coronary drug-eluting stenting: Understanding and modeling the risk.
Catheter Cardiovasc Interv;
98(2): 246-254, 2021 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32426935
4.
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III Trial.
Circulation;
140(23): 1895-1903, 2019 12 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31553222
5.
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
N Engl J Med;
377(16): 1513-1524, 2017 10 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28844193
6.
Association of adoption of transradial access for percutaneous coronary intervention in ST elevation myocardial infarction with door-to-balloon time.
Catheter Cardiovasc Interv;
96(2): E165-E173, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32105411
7.
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.
Circ Res;
122(3): 479-488, 2018 02 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29208679
8.
Three-Year Outcomes With the Absorb Bioresorbable Scaffold: Individual-Patient-Data Meta-Analysis From the ABSORB Randomized Trials.
Circulation;
137(5): 464-479, 2018 01 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29089314
9.
Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial.
Lancet;
392(10157): 1530-1540, 2018 10 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30266412
10.
Angiographic predictors of adverse outcomes after percutaneous coronary intervention in patients with radiation associated coronary artery disease.
Catheter Cardiovasc Interv;
94(3): E104-E110, 2019 Sep 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30690850
11.
Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials.
Eur Heart J;
39(19): 1726-1735a, 2018 05 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29668889
12.
2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy.
Lancet;
390(10096): 760-772, 2017 Aug 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28732815
13.
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.
N Engl J Med;
373(20): 1905-15, 2015 Nov 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26457558
14.
Fractional flow reserve guided percutaneous coronary intervention results in reduced ischemic myocardium and improved outcomes.
Catheter Cardiovasc Interv;
92(4): 692-700, 2018 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29405553
15.
1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis.
Lancet;
387(10025): 1277-89, 2016 Mar 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26825231
16.
Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.
Catheter Cardiovasc Interv;
89(2): E64-E74, 2017 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27220088
17.
Feasibility of transradial primary percutaneous coronary intervention for STEMI complicated by cardiac arrest.
Catheter Cardiovasc Interv;
99(4): 1363-1365, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35441817
18.
Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.
Circ Res;
116(1): 99-107, 2015 Jan 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25406300
19.
Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.
Am Heart J;
179: 142-50, 2016 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27595689
20.
Management of drug eluting stent in-stent restenosis: A systematic review and meta-analysis.
Catheter Cardiovasc Interv;
87(6): 1080-91, 2016 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26613637